Swan Capital’s Exact Sciences EXAS Stock Holding History

Swan Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,600	Closed	-$162K	–	575
2025 Q4	$162K	Hold	1,600	–	–	0.06%	45
2025 Q3	$87.5K	Sell	1,600 -400	-20%	-$20K	0.04%	60
2025 Q2	$106K	Hold	2,000	–	–	0.05%	51
2025 Q1	$86.6K	Hold	2,000	–	–	0.04%	50
2024 Q4	$112K	Hold	2,000	–	–	0.05%	45
2024 Q3	$136K	Hold	2,000	–	–	0.07%	41
2024 Q2	$84.5K	Buy	+2,000	New	+$110K	0.05%	53

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swan Capital's EXAS Position: Q1 2026 in Review

Swan Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,600 shares — an estimated $162K sold.

Swan Capital first reported a position in EXAS in Q2 2024 and held it in 7 quarters. The position peaked at $162K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Swan Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Swan Capital sold 1,600 Exact Sciences shares in Q1 2026, an estimated $162K.
Swan Capital first reported a position in Exact Sciences in Q2 2024 and held it in 7 quarters.
Swan Capital's Exact Sciences position peaked at $162K in Q4 2025.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.